At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 2 Part, Randomized, Open-Label, Single Dose, Crossover Study to Assess the Relative Bioavailability of Phase II Tablet Formulation Compared to the Current Phase I Capsule Formulation and the Effect of Food and Taste Assessment on the Phase II Tablet Formulation in Healthy Participants
In Brief
A Phase 1 clinical trial evaluating RO7017773 Phase I Capsule, RO7017773 Phase II Tablet Unflavored, and 1 other intervention for Healthy Volunteers. Completed, enrolled 24 participants across 1 site.
Detailed Summary
This is a two-part, open-label, healthy volunteer study. Part I will investigate the relative bioavailability of capsule and tablet formulations of RO7017773. Part II will explore how the taste of the tablet formulation is perceived with and without added sweetener/flavoring.
Study Details
Timeline
Interventions
Participants will receive 1 single oral dose of RO7017773 Phase I Capsule.
Participants will receive 3 single oral doses of unflavored RO7017773 Phase II tablet during Part 1, and 1 single oral dose of unflavored RO7017773 Phase II tablet during Part 2.
Participants will receive 1 single oral dose of sweetened/flavored RO7017773 Phase II tablet during Part 2.